Genentech, OSI Pay $67M To Settle Cancer Drug False Claims Lawsuit
(June 7, 2016, 12:31 PM EDT) -- SAN FRANCISCO — Genentech Inc. and OSI Pharmaceuticals LLC on June 6 agreed to pay $67 million to resolve a False Claims Act lawsuit alleging that they misrepresented the effectiveness of...
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login